Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1).

Nature cell biology | May 3, 2002

http://www.ncbi.nlm.nih.gov/pubmed/11988738

Emi1 promotes mitotic entry in Xenopus laevis embryos by inhibiting the APC(Cdc20) ubiquitination complex to allow accumulation of cyclin B. We show here that human Emi1 (hEmi1) functions to promote cyclin A accumulation and S phase entry in somatic cells by inhibiting the APC(Cdh1) complex. At the G1-S transition, hEmi1 is transcriptionally induced by the E2F transcription factor, much like cyclin A. hEmi1 overexpression accelerates S phase entry and can override a G1 block caused by overexpression of Cdh1 or the E2F-inhibitor p105 retinoblastoma protein (pRb). Depleting cells of hEmi1 through RNA interference prevents accumulation of cyclin A and inhibits S phase entry. These data suggest that E2F can activate both transcription of cyclin A and the hEmi1-dependent stabilization of APC(Cdh1) targets, such as cyclin A, to promote S phase entry.

Pubmed ID: 11988738 RIS Download

Mesh terms: Anaphase-Promoting Complex-Cyclosome | Animals | Cell Cycle Proteins | Cyclin A | DNA-Binding Proteins | E2F Transcription Factors | F-Box Proteins | Fibroblasts | HeLa Cells | Humans | Ligases | Recombinant Fusion Proteins | S Phase | Transcription Factors | Tumor Cells, Cultured | Ubiquitin | Ubiquitin-Protein Ligase Complexes | Xenopus Proteins | Xenopus laevis

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA09302
  • Agency: NIGMS NIH HHS, Id: GM07365
  • Agency: NIGMS NIH HHS, Id: GM54811
  • Agency: NIGMS NIH HHS, Id: GM60439

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.